Interactive Decision Support Tool

Share

Program Content

Activities

  • Monitoring Response to BCR-ABL1 inhibitors in CML
    Chronic Myeloid Leukemia Interactive Decision Support Tool: Expert Guidance on Monitoring Response to BCR-ABL1 Inhibitors in CML
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 30, 2022

    Expires: March 29, 2023

Provided by

ProCE Banner

Supporters

Novartis Pharmaceuticals Corporation

Pfizer, Inc.